Catalyst Wire Dossier Catalyst Wire Dossier

Belotero

hyaluronic acid dermal filler · Merz North America, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Belotero, covering 2012-01-19 to 2022-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational [Phase 4]

See pricing